Cladribine regimen for treating multiple sclerosis | Patent Number 07713947

US 07713947 B2
Application Number11722018
Publication NumberUS 20090081163 A1
Pendency4 years, 4 months, 23 days
Filled DateDec 20, 2005
Priority DateDec 22, 2004
Publication DateMar 26, 2009
Expiration DateDec 22, 2024
Inventor/ApplicantsMaria Lopez-Bresnahan
Giampiero De Luca
Arnaud Ythier
Alain Munafo
ExaminesBALLARD, KIMBERLY
Art Unit1649
Technology Center1600
Assignments
Merck Serono Sa
Current
Merck Serono SaMerck & Co. Inc.
Original
Laboratoires Serono Sa
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.